Clinical outcome of nivolumab in older and frail patients with recurrent/metastatic head and neck squamous cell carcinoma

J Geriatr Oncol. 2023 Jan;14(1):101380. doi: 10.1016/j.jgo.2022.09.009. Epub 2022 Sep 27.

¹ Radiation Oncology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
² Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy. Electronic address: marc.ba12@gmail.com.
³ Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.
⁴ Radiation Oncology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.

No abstract available

Keywords: Geriatric oncology; Head and neck cancer; Immunotherapy; Nivolumab; Older patients.

MeSH terms